PT

Dados B3 › Restatements

Has BRADSAÚDE S.A. (SAUD3) ever restated its financial statements? In which years?

Yes: the statements for 2012, 2013, 2022, 2023, 2024 came back with different figures in the following year's annual filing — 29 account(s) in all, each below with both values.

YearAccountAs first filedAs restatedDifferenceRevealed in (CVM file)
2012current liabilities (BPP 2.01)R$ 169.1 mR$ 206.0 m17.9%DFP 2013 · 10/03/2014
2012current assets (BPA 1.01)R$ 271.3 mR$ 308.3 m12.0%DFP 2013 · 10/03/2014
2012total assets (BPA 1)R$ 982.7 mR$ 1.02 bn3.6%DFP 2013 · 10/03/2014
2012total liabilities (BPP 2)R$ 982.7 mR$ 1.02 bn3.6%DFP 2013 · 10/03/2014
2013current assets (BPA 1.01)R$ 338.0 mR$ 347.4 m2.7%DFP 2014 · 04/03/2015
2013net operating cash flow (DFC_MI 6.01)R$ 210.1 mR$ 209.0 m0.5%DFP 2014 · 04/03/2015
2022gross profit (DRE 3.03)R$ 1.15 bnR$ 479.0 m58.4%DFP 2023 · 28/02/2024
2022cost of goods and services (DRE 3.02)R$ -726.4 mR$ -1.35 bn46.0%DFP 2023 · 28/02/2024
2022current assets (BPA 1.01)R$ 424.5 mR$ 259.8 m38.8%DFP 2023 · 28/02/2024
2022net income plus OCI (DMPL 5.05)R$ 452.3 mR$ 338.0 m25.3%DFP 2023 · 28/02/2024
2022income taxes (DRE 3.08)R$ -184.4 mR$ -139.3 m24.5%DFP 2023 · 28/02/2024
2022profit before taxes (DRE 3.07)R$ 636.6 mR$ 505.1 m20.6%DFP 2023 · 28/02/2024
2022profit in the statement of changes in equity (DMPL 5.05.01)R$ 452.2 mR$ 365.9 m19.1%DFP 2023 · 28/02/2024
2022profit from continuing operations (DRE 3.09)R$ 452.2 mR$ 365.9 m19.1%DFP 2023 · 28/02/2024
2022net profit (DRE 3.11)R$ 452.2 mR$ 365.9 m19.1%DFP 2023 · 28/02/2024
2022profit attributable to controlling shareholders (DRE 3.11.01)R$ 452.2 mR$ 365.9 m19.1%DFP 2023 · 28/02/2024
2022operating profit (EBIT) (DRE 3.05)R$ 566.1 mR$ 469.6 m17.0%DFP 2023 · 28/02/2024
2022current liabilities (BPP 2.01)R$ 677.5 mR$ 599.0 m11.6%DFP 2023 · 28/02/2024
2022total assets (BPA 1)R$ 1.97 bnR$ 1.84 bn6.8%DFP 2023 · 28/02/2024
2022total liabilities (BPP 2)R$ 1.97 bnR$ 1.84 bn6.8%DFP 2023 · 28/02/2024
2022opening equity (DMPL 5.03)R$ 1.12 bnR$ 1.17 bn4.9%DFP 2023 · 28/02/2024
2022equity (BPP 2.03)R$ 1.18 bnR$ 1.13 bn4.8%DFP 2023 · 28/02/2024
2022closing equity (DMPL 5.07)R$ 1.18 bnR$ 1.13 bn4.8%DFP 2023 · 28/02/2024
2022net revenue (DRE 3.01)R$ 1.88 bnR$ 1.83 bn2.7%DFP 2023 · 28/02/2024
2023gross profit (DRE 3.03)R$ 654.7 mR$ 696.0 m5.9%DFP 2024 · 26/02/2025
2023cost of goods and services (DRE 3.02)R$ -1.46 bnR$ -1.42 bn2.8%DFP 2024 · 26/02/2025
2024net operating cash flow (DFC_MI 6.01)R$ 594.5 mR$ 527.5 m11.3%DFP 2025 · 27/02/2026
2024gross profit (DRE 3.03)R$ 783.0 mR$ 790.9 m1.0%DFP 2025 · 27/02/2026
2024cost of goods and services (DRE 3.02)R$ -1.50 bnR$ -1.49 bn0.5%DFP 2025 · 27/02/2026

How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. Descriptive, not investment advice.

SAUD3 — company page · all restatements in the base

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:56 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:56 UTC. If this does not match /saude, you are reading a cached copy.